Redraws Are Expensive: Building a Simple Cost Model Your CFO Will Love

Why Phlebotomy Waste Is a Finance Problem, Not Just a Clinical One

Most laboratory directors and phlebotomy supervisors think about hemolysis and redraws in clinical terms — compromised specimens, delayed results, frustrated patients. Finance teams think in dollars. Bridging that language gap is how you get budget approval for better equipment, standardized workflows, and sharps safety upgrades. This post gives you a straightforward total cost of ownership (TCO) framework that translates everyday phlebotomy inefficiencies into the numbers a Chief Financial Officer (CFO) will actually read.

The Real Cost of a Single Hemolyzed Specimen

A hemolyzed specimen is rarely just one wasted tube. It triggers a chain of events — clinician notification, patient recall or re-stick, repeat venipuncture, re-processing, and re-reporting — each carrying a labor and supply cost. 

Start your model with three inputs your lab already tracks:

- Hemolysis rejection rate (%) — many laboratories target hemolysis rates in the low single digits (often below 2–3%) through CLSI GP41 process controls

- Monthly blood draw volume — pull this from your Laboratory Information System (LIS)

- Average cost per redraw — include nurse or phlebotomist time, supplies, and any downstream repeat testing fees

Example: A 400-bed hospital performing 10,000 draws per month at a 4% hemolysis rate generates 400 redraws. At a conservative $25 per redraw in combined labor and supply cost, which is $10,000 per month — $120,000 per year — leaving the budget before anyone notices.

Quantifying Re-Sticks and Patient Experience Costs

Re-sticks carry costs beyond supplies. Each additional venipuncture attempt adds phlebotomist time (typically 8–12 minutes per event), increases needlestick injury risk as staff handle more sharps, and directly impacts patient satisfaction scores. Under value-based reimbursement models, patient experience data from the Centers for Medicare and Medicaid Services (CMS) is tied to reimbursement rates, meaning a poor draw experience has a revenue consequence that extends well beyond the lab.

Build a second row in your model:

- Re-stick rate (%) — first-attempt success benchmarks vary, but rates below 90% warrant investigation

- Staff time cost per re-stick — use your facility's fully burdened labor rate for phlebotomists or nurses

- Patient satisfaction penalty estimate — work with your finance team to assign even a conservative dollar figure to Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) score impact

Minutes Lost at Scale — The Hidden Labor Sink

Time is your largest variable cost. A phlebotomist spending an extra 10 minutes per shift resolving hemolysis issues, tracking down clinicians, or completing a second draw on the same patient adds up quickly. At 20 phlebotomists working 250 days per year, 10 extra minutes per shift per person equals over 833 hours of lost labor annually. Multiply that by a $22/hour fully burdened rate and you have an $18,000 annual figure that never appeared on a supply budget.

OSHA's bloodborne pathogen standards also require documentation and follow-up for any sharps injury — typically 30–60 minutes of administrative time per incident. Factor needlestick incident rates into your model as a separate line item using your facility's actual Exposure Control Plan records.

Building Your TCO Model — A One-Page Framework

Structure your model with five rows and two columns (current state vs. optimized state):

1. Hemolysis-driven redraws — volume × rejection rate × cost per redraw

2. Re-stick labor cost — re-stick events × minutes × fully burdened hourly rate

3. Sharps injury administration — annual incident count × estimated cost per incident ($2,000–$5,000 per needlestick incident is a commonly cited range)

4. Supply waste — tubes, needles, bandages, and gloves consumed in failed or repeated draws

5. Patient satisfaction / reimbursement impact — conservative estimate tied to HCAHPS or payer mix

The "optimized state" column reflects outcomes after implementing safety-engineered collection devices, standardized draw order, and competency-based training. Even a 30% reduction in hemolysis rate and a 50% reduction in needlestick incidents produces savings most CFOs will act on.

90-Day Action Plan to Build and Present Your Cost Model

Phase 1 — Days 1–30: Data Collection

1. Pull three months of hemolysis rejection rates from your LIS.

2. Request phlebotomy re-stick logs and first-attempt success data from supervisors.

3. Obtain fully burdened labor rates from Human Resources (HR) for all staff who perform draws.

Phase 2 — Days 31–60: Model Build and Validation

4. Populate the five-row TCO framework with your facility's actual figures.

5. Benchmark your hemolysis rate against CLSI GP41 and national averages.

6. Present a draft model to your lab director and one finance liaison for feedback.

Phase 3 — Days 61–90: Stakeholder Presentation and Procurement Decision

7. Prepare a one-page executive summary with current-state cost and projected savings.

8. Schedule a 20-minute CFO or VP of Finance meeting with the annual dollar figure.

9. Issue a Request for Information (RFI) or trial request for safety blood collection sets.

Explore RELI® Blood Collection Solutions

MYCO Medical's RELI® blood collection line is engineered to reduce hemolysis risk through consistent, controlled blood flow and passive needle retraction that activates automatically — reducing re-stick rates and sharps injury exposure simultaneously. For one-touch activation, the RELI® Push Button Safety Blood Collection Set gives clinicians active control with a single-hand press. Dual-use environments benefit from the RELI® Safety Slide™ Blood Collection/Infusion Set, which supports both blood draws and IV infusion in one device. Facilities that supply their own tube holders can pair their preferred holder with the RELI® Safety Blood Collection Needle for a flexible, cost-effective setup.

Frequently Asked Questions

What is considered an acceptable hemolysis rejection rate?

Most laboratories target below 2–3% per CLSI GP41 guidance. Rates consistently above 3% indicate a technique, equipment, or training gap that warrants investigation.

How do I calculate the fully burdened labor rate for my cost model?

Fully burdened rate includes base wage, payroll taxes, benefits, and overhead. Ask your HR or finance department — most facilities calculate this at 1.25–1.4× the base hourly wage.

Can safety-engineered devices actually reduce hemolysis?

Yes. Passive retraction mechanisms and controlled-flow needle designs reduce turbulent blood flow during collection, which is a documented contributor to in-vitro hemolysis.

What data do I need before approaching my CFO?

At minimum: monthly draw volume, hemolysis rejection rate, re-stick frequency, and your facility's fully burdened labor rate. Three months of data provides a credible baseline.

Are needlestick injury costs really that significant?

Yes. The CDC estimates direct costs per needlestick incident — including testing, prophylaxis, and follow-up — can reach thousands of dollars, not counting lost productivity or liability exposure.

How does standard work reduce phlebotomy costs?

Standardizing draw order, tube fill sequence, and device selection eliminates variation that causes hemolysis and re-sticks. Consistent protocols reduce the per-draw cost floor across your entire volume.

‍